These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30215635)

  • 1. Targeted therapies for psoriatic arthritis: an update for the dermatologist.
    Elman SA; Weinblatt M; Merola JF
    Semin Cutan Med Surg; 2018 Sep; 37(3):173-181. PubMed ID: 30215635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriatic arthritis for the dermatologist.
    Tintle SJ; Gottlieb AB
    Dermatol Clin; 2015 Jan; 33(1):127-48. PubMed ID: 25412788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New targets in psoriatic arthritis.
    Braun J
    Rheumatology (Oxford); 2016 Dec; 55(suppl 2):ii30-ii37. PubMed ID: 27856658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Psoriasis Treatment Pipeline: An Overview and Update.
    Hawkes JE; Al-Saedy M; Bouché N; Al-Saedy S; Drew DT; Song EJ
    Dermatol Clin; 2024 Jul; 42(3):365-375. PubMed ID: 38796268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
    Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J
    Arthritis Rheumatol; 2019 Jan; 71(1):5-32. PubMed ID: 30499246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA.
    Baum EW; Schwartzman S
    Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted synthetic pharmacotherapy for psoriatic arthritis: state of the art.
    Caso F; Navarini L; Ruscitti P; Chimenti MS; Girolimetto N; Del Puente A; Giacomelli R; Scarpa R; Costa L
    Expert Opin Pharmacother; 2020 May; 21(7):785-796. PubMed ID: 32057269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of disease: psoriasis and psoriatic arthritis.
    Boehncke WH; Menter A
    Am J Clin Dermatol; 2013 Oct; 14(5):377-88. PubMed ID: 23771648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.
    Yiu ZZ; Warren RB
    Am J Clin Dermatol; 2016 Jun; 17(3):191-200. PubMed ID: 26923915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apremilast for the treatment of psoriatic arthritis.
    Souto A; Gómez-Reino JJ
    Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis.
    James WA; Rosenberg AL; Wu JJ; Hsu S; Armstrong A; Wallace EB; Lee LW; Merola J; Schwartzman S; Gladman D; Liu C; Koo J; Hawkes JE; Reddy S; Prussick R; Yamauchi P; Lewitt M; Soung J; Weinberg J; Lebwohl M; Glick B; Kircik L; Desai S; Feldman SR; Zaino ML
    J Am Acad Dermatol; 2024 Aug; 91(2):251.e1-251.e11. PubMed ID: 38499181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing and treating psoriatic arthritis: an update.
    Boehncke WH; Qureshi A; Merola JF; Thaçi D; Krueger GG; Walsh J; Kim N; Gottlieb AB
    Br J Dermatol; 2014 Apr; 170(4):772-86. PubMed ID: 24266754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule therapy for managing moderate to severe psoriatic arthritis.
    Costa L; Del Puente A; Peluso R; Tasso M; Caso P; Chimenti MS; Sabbatino V; Girolimetto N; Benigno C; Bertolini N; Del Puente A; Perricone R; Scarpa R; Caso F
    Expert Opin Pharmacother; 2017 Oct; 18(15):1557-1567. PubMed ID: 28891341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of psoriatic arthritis with traditional DMARD's and novel therapies: approaches and recommendations.
    Maharaj AB; Chandran V
    Expert Rev Clin Immunol; 2017 Apr; 13(4):319-331. PubMed ID: 27826996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.
    Gossec L; Baraliakos X; Kerschbaumer A; de Wit M; McInnes I; Dougados M; Primdahl J; McGonagle DG; Aletaha D; Balanescu A; Balint PV; Bertheussen H; Boehncke WH; Burmester GR; Canete JD; Damjanov NS; Kragstrup TW; Kvien TK; Landewé RBM; Lories RJU; Marzo-Ortega H; Poddubnyy D; Rodrigues Manica SA; Schett G; Veale DJ; Van den Bosch FE; van der Heijde D; Smolen JS
    Ann Rheum Dis; 2020 Jun; 79(6):700-712. PubMed ID: 32434812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.
    Gan EY; Chong WS; Tey HL
    BioDrugs; 2013 Aug; 27(4):359-73. PubMed ID: 23580094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial Characteristics as Contextual Factors When Evaluating Targeted Therapies in Patients With Psoriatic Disease: A Meta-Epidemiologic Study.
    Ballegaard C; Jørgensen TS; Skougaard M; Strand V; Mease PJ; Kristensen LE; Dreyer L; Gottlieb A; de Wit M; Christensen R; Tarp S
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1206-1217. PubMed ID: 29073353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the diagnosis and management of psoriatic arthritis.
    Weger W
    G Ital Dermatol Venereol; 2011 Feb; 146(1):1-8. PubMed ID: 21317852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.